← Eichor
Condition: Catecholaminergic Polymorphic Ventricular Tachycardia Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Catecholaminergic Polymorphic Ventricular Tachycardia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Evaluation of Exercise Testing and Physical Activity in Children and Adolescents Living With Inherited Arrhythmias
Phase N/A · 2 location(s) · Royal Brompton & Harefield NHS Foundation Trust · NCT06661278China Inherited Ventricular Arrhythmias Registry
Phase N/A · 1 location(s) · China National Center for Cardiovascular Diseases · NCT03880708Clinical Cohort Study - TRUST
Phase N/A · 1 location(s) · Universitätsklinikum Hamburg-Eppendorf · NCT05521451A Study of SGT-501 Gene Therapy in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
Phase 1 · 5 location(s) · Solid Biosciences Inc. · NCT07148089Safety, Tolerability, and Exploratory Efficacy of AGP100 in Patients With Catecholaminergic Polymorphic Ventricular Tach
Phase 2 · 1 location(s) · Agiana Pharmaceuticals · NCT07263139A Phase 2 Study of CRD-4730 in CPVT
Phase 2 · 12 location(s) · Cardurion Pharmaceuticals, Inc. · NCT06658899Genetic Markers of Cardiovascular Disease in Epilepsy
Phase N/A · 1 location(s) · Mayo Clinic · NCT02824822National Network for Cardiovascular Genomics: Advancing Cardiovascular Healthcare for Hereditary Diseases in Brazil's Un
Phase N/A · 27 location(s) · Hospital do Coracao · NCT06546137
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.